Introduction & Market Context Legend Biotech Corporation (NASDAQ: LEGN) presented its first quarter 2025 financial results and corporate update on May 13, 2025, highlighting the continued commercial ...

Vir Biotechnology, Inc. (NASDAQ ... This example is presented on slide #12 of the Company's February 2025 Corporate Presentation. Specifically, approximately 90% of HDV patients who took the ...

Krystal Biotech reported net product revenue of $88.2 million for VYJUVEK in Q1 2025, representing a 95% increase compared to Q1 2024, but a sequential decline from $91.1 million in Q4 2024. The ...

The Biotechnology segment, which includes the Cytiva brand, delivered revenue of $1,612 million, representing a solid increase of 6.0%. Core growth was even stronger at 7.0%, partially offset by a ...

Shares of several biotech and biopharma names are under pressure on Monday following the resignation of the head of the Food and Drug Administration’s Center for Biologics Evaluation and ...

The weekend's resignation announcement of FDA official Peter Marks hit biotech stocks on Monday and sent Wall Street into a frenzy of concern over the future of biopharma approvals in the near term.

COLORADO SPRINGS, Colo. (KRDO) - A rock slide Wednesday evening near the town of Howard shut down Highway 50 in both directions, with no estimated time of reopening. The Colorado State Patrol ...

Stock falls 12.8% after mid-stage trial fails to meet its main goal Sage Therapeutics Inc.'s stock tumbled 12.8% early Tuesday, after the company said it would cease development of a treatment for ...

Sage Therapeutics Inc.’s stock tumbled 5% Tuesday, after the company said it would cease development of a treatment for mild cognitive impairment and mild dementia in Alzheimer’s disease due ...

At the biotechnology event, hosted at the Kite Gilead campus adjacent to Bergamot Station Arts Center, Kite and SMC faculty discussed opportunities for SMC students in the ambitious industry ...